AI assistant
CERILLION PLC — Earnings Release 2018
Oct 22, 2018
7556_rns_2018-10-22_d3fc72d5-56c9-4c4b-b4b1-0380cd681343.html
Earnings Release
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6325E
Cerillion PLC
22 October 2018
AIM: CER
Cerillion plc
("Cerillion" or "the Company")
Trading Update
Cerillion, the billing, charging and customer relationship management ("CRM") software solutions provider, is pleased to provide a trading update for its financial year ended 30 September 2018.
Results for the year are expected to be in line with current market expectations, with revenues up by 8% year-on-year to circa £17.4m and adjusted EBITDA up by 9% to circa £3.9m.
Trading in the second half of the financial year has been very encouraging, well supported by new orders. The Company is advancing with contract negotiations with major potential new customers, and its new business pipeline, including the range and quality of opportunities, remains very positive.
The Company intends to announce full year results towards the end of November.
| Cerillion plc | c/o KTZ Communications |
| Louis Hall, CEO | T: 020 3178 6378 |
| Oliver Gilchrist, CFO | |
| Shore Capital (Nomad and broker) | T: 020 7408 4090 |
| Toby Gibbs, Mark Percy | |
| KTZ Communications | T: 020 3178 6378 |
| Katie Tzouliadis, Emma Pearson |
About Cerillion
www.cerillion.com
Cerillion is a leading provider of mission critical software for billing, charging and CRM. The Company has over 80 customer installations across over 40 countries, principally serving the telecommunications market.
Headquartered in London, Cerillion also has operations in Pune, India, where its Global Solutions Centre is located, Miami and Sydney.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
TSTDMMMGGLNGRZM